In the genes with diagnostic or prognostic value, loss-of-function mutations in TP53 were most prevalent (32%) detected in all three tumor types, followed by deleterious mutations in the tumor suppressor genes APC, FBXW7 and SMAD4 in CRC, and CDKN2A in MELA. This evidence concerns the gene TP53 and colorectal carcinoma.